INTELLIGENCE IN ACTION

New York Takes the Lead in EPCS

February 01, 2016

NY State EPCS infogram_LI_1064x800 (1)Today, Surescripts released new data about its Electronic Prescribing of Controlled Substances (EPCS) solution, and how it’s helping New York tackle prescription drug abuse. In fact, prescribers in New York are adopting EPCS at five times the national rate of 5.8 percent. New York’s prescribers are embracing EPCS, and 27 percent of total prescribers are enabled to digitally prescribe controlled substances.

Surescripts’ Ken Whittemore, Senior Vice President of Professional and Regulatory Affairs, said, “Physicians in New York have done a really nice job in preparing for this change. Pharmacies have stepped up in a very big way as well. New York’s impressive adoption rate shows its healthcare community’s commitment to not only meeting the I-STOP mandate, but also recognizing one of the state’s most pressing and alarming healthcare challenges.”

I-STOP is the Internet System for Tracking Over-Prescribing (I-STOP) mandate, which requires that all prescriptions be transmitted electronically in New York by March 27, 2016.

The mandate, which was previously slated for March 27 of last year, was delayed due to political and industry concerns, as well as the Long Term Care market’s sense of unpreparedness.

Whittemore is hopeful that the gap in adoption will close quickly, especially as the steps to comply are similar to other processes physicians and pharmacies regularly deal with.

“There’s still time to implement and adopt EPCS, “said Whittemore. “It certainly takes a bit of work for prescribers to complete identity proofing and credentialing, but the process isn’t all that different from others in terms of time and effort. And the great part is, once it’s done, it’s done.”

Visit getEPCS.com to review the steps to enabling the electronic transmission of controlled substance prescriptions. 

Related Articles

November 11, 2019

50 Days and Counting: Take These Necessary Steps to Meet EPCS Requirements

Fraud and abuse are prevalent in the world of prescription painkillers. In 2017, a total of 61,311 people died from drug overdoses – with an estimated 40% from prescription opioid medicine. This is 61,311 too many. Opioid diversion is a significant cause of opioid misuse, with between 3% and 9% of diverted drugs tied to fraud or forgery of paper prescriptions.

Read more...
October 22, 2019

Now Trending: EPCS Among Physicians and Medicare Part D Patients

As we approach the one-year anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, I am optimistic about the direction of a key provision outlined in the legislation, that is, the use of electronic prescribing of controlled substance (EPCS) among Medicare Part D providers.  Read more...
July 30, 2019

Lessons Learned: How Connecticut Implemented an EPCS Requirement That Was Effective and Embraced by the Medical Community

Connecticut’s Electronic Prescribing of Controlled Substances (EPCS) requirement came into effect in January 2018. As Drug Control Director, I often serve as an advisor to state legislators who want to ensure the bills they draft are effective once they become law, so I was very active in the 2017 legislative session. While crafting this bill, we looked at how other states managed implementation of EPCS and worked closely with medical professionals to ensure that our legislation was thoughtful. We knew we had to consider the day-to-day operations of regulators and medical professionals, and ultimately what was best for patients.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX